Molecular & cellular oncology

A new "angle" on kinase inhibitor design: Prioritizing amphosteric activity above kinase inhibition.

Molecular & cellular oncology

Meyerowitz JG, Weiss WA, Gustafson WC

Atg12–Atg3 Coordinates Basal Autophagy, Endolysosomal Trafficking, and Exosome Release.

Molecular & cellular oncology

Lyndsay Murrow, Jayanta Debnath

ETS1 inactivation causes innate drug resistance to EGFR inhibitors.

Molecular & cellular oncology

Tetsu O, Phuchareon J, Eisele DW, McCormick F